Your browser doesn't support javascript.
loading
Subcutaneous bortezomib combined with weekly cyclophosphamide and dexamethasone is an efficient and well tolerated regime in newly diagnosed multiple myeloma.
Ong, Shin-Yeu; Ng, Hong Yen; Surendran, Shilpa; Linn, Yeh Ching; Chen, YunXin; Goh, Yeow Tee; Diong, Colin; Gopalakrishnan, Sathish Kumar.
  • Ong SY; Department of Haematology, Singapore General Hospital, Singapore, Singapore.
  • Ng HY; Department of Pharmacy, Singapore General Hospital, Singapore, Singapore.
  • Surendran S; Department of Haematology, Singapore General Hospital, Singapore, Singapore.
  • Linn YC; Department of Haematology, Singapore General Hospital, Singapore, Singapore.
  • Chen Y; Department of Haematology, Singapore General Hospital, Singapore, Singapore.
  • Goh YT; Department of Haematology, Singapore General Hospital, Singapore, Singapore.
  • Diong C; Department of Haematology, Singapore General Hospital, Singapore, Singapore.
  • Gopalakrishnan SK; Department of Haematology, Singapore General Hospital, Singapore, Singapore. sathish.gopalakrishnan@sgh.com.sg.
Br J Haematol ; 169(5): 754-6, 2015 Jun.
Article en En | MEDLINE | ID: mdl-25413901
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Search on Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Protocolos de Quimioterapia Combinada Antineoplásica / Mieloma Múltiple Tipo de estudio: Diagnostic_studies / Systematic_reviews Límite: Humans Idioma: En Año: 2015 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Search on Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Protocolos de Quimioterapia Combinada Antineoplásica / Mieloma Múltiple Tipo de estudio: Diagnostic_studies / Systematic_reviews Límite: Humans Idioma: En Año: 2015 Tipo del documento: Article